Search Results - "Clézardin, P."

Refine Results
  1. 1
  2. 2

    Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs by Stresing, V, Baltziskueta, E, Rubio, N, Blanco, J, Arriba, MaC, Valls, J, Janier, M, Clézardin, P, Sanz-Pamplona, R, Nieva, C, Marro, M, Dmitri, P, Sierra, A

    Published in Oncogene (07-02-2013)
    “…Little is known about metastatic pathways that are specific to the lung rather than other organs. We previously showed that antioxidant proteins such as…”
    Get full text
    Journal Article
  3. 3

    The RANK–RANKL axis: an opportunity for drug repurposing in cancer? by Peters, S., Clézardin, P., Márquez-Rodas, I., Niepel, D., Gedye, C.

    Published in Clinical & translational oncology (01-08-2019)
    “…Drug repurposing offers advantages over traditional drug development in terms of cost, speed and improved patient outcomes. The receptor activator of nuclear…”
    Get full text
    Journal Article
  4. 4

    Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo by Gibert, B, Eckel, B, Gonin, V, Goldschneider, D, Fombonne, J, Deux, B, Mehlen, P, Arrigo, A-P, Clézardin, P, Diaz-Latoud, C

    Published in British journal of cancer (26-06-2012)
    “…Background: The small stress heat shock protein 27 (Hsp27) has recently turned as a promising target for cancer treatment. Hsp27 upregulation is associated…”
    Get full text
    Journal Article
  5. 5

    Increased Dickkopf-1 expression in breast cancer bone metastases by Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, J J, Clézardin, P, Garnero, P

    Published in British journal of cancer (08-10-2007)
    “…The aim of this study was to determine whether Dickkopf-1 (Dkk-1) expression in breast cancer was associated with bone metastases. We first analysed Dkk-1…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma by Massy, E, Rousseau, JC, Gueye, M., Bonnelye, E., Brevet, M., Chambard, L., Duruisseaux, M., Borel, O., Roger, C., Guelminger, R., Pialat, J.B., Gineyts, E., Bouazza, L., Millet, M., Maury, JM, Clézardin, P., Girard, N., Confavreux, Cyrille B.

    Published in Journal of bone oncology (01-08-2021)
    “…•Matrix protein periostin is involved in cancer cell dissemination and bone response.•Serum periostin level was higher in adenocarcinoma lung cancer patients…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells by Arkko, S, Zlatev, H.P, Mönkkönen, H, Räikkönen, J, Benzaïd, I, Clézardin, P, Mönkkönen, J, Määttä, J.A

    Published in Cancer letters (01-02-2015)
    “…Highlights • PC-3 prostate cancer cells treated with zoledronate were shown to be resistant to Vγ9Vδ2 T cell cytotoxicity. • Resistance was attributed to the…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Integrins in bone metastasis formation and potential therapeutic implications by Clëzardin, P

    Published in Current cancer drug targets (01-11-2009)
    “…Integrins constitute a family of cell surface receptors that are heterodimers composed of noncovalently associated alpha and beta subunits. Integrins bind to…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Propriétés antitumorales du bisphosphonate zolédronate et implications thérapeutiques potentielles en clinique by CLEZARDIN, P

    Published in Bulletin du cancer (01-08-2010)
    “…Le zolédronate ainsi que les autres bisphosphonates inhibent la résorption osseuse en bloquant l'activité des ostéoclastes. C'est pour cette raison qu'ils sont…”
    Get full text
    Journal Article